Literature DB >> 26667584

Frequency and temporal profile of recanalization after cerebral vein and sinus thrombosis.

C Herweh1, M Griebe2, C Geisbüsch3, K Szabo2, E Neumaier-Probst4, M G Hennerici2, M Bendszus1, P A Ringleb3, S Nagel3.   

Abstract

BACKGROUND AND
PURPOSE: The temporal course of recanalization and its association with clinical outcome were analysed in our patients with cerebral sinus and/or venous thrombosis (CSVT) and follow-up magnetic resonance imaging (MRI).
METHODS: Between January 1998 and September 2014 all patients from our institutions with CSVT were systematically analysed. Baseline data, treatment characteristics and follow-up MRI were retrospectively recorded. The status of recanalization was assessed as complete (CRec), partial (PRec) or failed recanalization. Clinical follow-up was measured with the modified Rankin Scale. Excellent outcome was defined as modified Rankin Scale 0-1.
RESULTS: Ninety-nine patients were identified; 97% of these patients were treated with oral anticoagulation (OAC) and the median (min-max) time of OAC was 7 months (1-84). CRec was achieved in 57.6% (57/99), PRec in 29.3% (29/99) and only 13 (13.1%) patients did not recanalize. The median (min-max) time to PRec was 4 months (0.25-14) and to CRec 6 months (2-34). Median time to last clinical follow-up was 8 months (1-88); 91.8% (89/99) had an excellent outcome at last clinical follow-up and only 2.1% (2/99) died. Only thrombosis of the superior sagittal sinus was independently associated with successful recanalization (odds ratio 16, 95% confidence interval 2-138). No severe haemorrhagic complications and no recurrence of CSVT occurred within clinical follow-up. No association of outcome and recanalization status was found.
CONCLUSIONS: The recanalization rate of CSVT under OAC was high and the median time to CRec was 6 months. Thrombosis of the superior sagittal sinus is a positive predictor of recanalization. Outcome in this cohort was excellent but no significant association of outcome and recanalization status was found.
© 2015 EAN.

Entities:  

Keywords:  anticoagulation; cerebral sinus and venous thrombosis; recanalization

Mesh:

Substances:

Year:  2015        PMID: 26667584     DOI: 10.1111/ene.12901

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  14 in total

1.  The efficacy and safety of Batroxobin in combination with anticoagulation on cerebral venous sinus thrombosis.

Authors:  Jiayue Ding; Da Zhou; Yanyu Hu; Omar Elmadhoun; Liqun Pan; Jingyuan Ya; Tingting Geng; Zhongao Wang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

Review 2.  Cerebral venous thrombosis.

Authors:  Suzanne M Silvis; Diana Aguiar de Sousa; José M Ferro; Jonathan M Coutinho
Journal:  Nat Rev Neurol       Date:  2017-08-18       Impact factor: 42.937

3.  [Diagnostic and treatment standards for cerebral sinus venous thrombosis : Results of an online survey of German stroke units].

Authors:  C Geisbüsch; P A Ringleb; O Busse; G F Hamann; S Nagel
Journal:  Nervenarzt       Date:  2017-10       Impact factor: 1.214

4.  Longitudinal Volume Quantification of Deep Medullary Veins in Patients with Cerebral Venous Sinus Thrombosis : Venous Volume Assessment in Cerebral Venous Sinus Thrombosis Using SWI.

Authors:  A K Dempfle; A Harloff; F Schuchardt; J Bäuerle; S Yang; H Urbach; K Egger
Journal:  Clin Neuroradiol       Date:  2017-06-06       Impact factor: 3.649

Review 5.  Evidence-Based Minireview: Should warfarin or a direct oral anticoagulant be used in patients presenting with thrombosis in the splanchnic or cerebral veins?

Authors:  Carol Mathew; Marc Zumberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

6.  Efficacy and safety of rivaroxaban in cerebral venous thrombosis: insights from a prospective cohort study.

Authors:  Liqun Pan; Mengqi Wang; Da Zhou; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  J Thromb Thrombolysis       Date:  2021-11-03       Impact factor: 2.300

7.  Chronic intracranial hypertension after cerebral venous and sinus thrombosis - frequency and risk factors.

Authors:  Christina Geisbüsch; Christian Herweh; Christoph Gumbinger; Peter A Ringleb; Markus A Möhlenbruch; Simon Nagel
Journal:  Neurol Res Pract       Date:  2021-05-17

Review 8.  Cerebral and Splanchnic Vein Thrombosis: Advances, Challenges, and Unanswered Questions.

Authors:  Nicoletta Riva; Walter Ageno
Journal:  J Clin Med       Date:  2020-03-10       Impact factor: 4.241

9.  Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review.

Authors:  Gauruv Bose; Justin Graveline; Vignan Yogendrakumar; Risa Shorr; Dean A Fergusson; Gregoire Le Gal; Jonathan Coutinho; Marcelo Mendonça; Miguel Viana-Baptista; Simon Nagel; Dar Dowlatshahi
Journal:  BMJ Open       Date:  2021-02-16       Impact factor: 2.692

10.  Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis.

Authors:  Marco Senzolo; Nicoletta Riva; Francesco Dentali; Kryssia Rodriguez-Castro; Maria Teresa Sartori; Soo-Mee Bang; Ida Martinelli; Sam Schulman; Adriano Alatri; Jan Beyer-Westendorf; Matteo Nicola Dario Di Minno; Walter Ageno
Journal:  Clin Transl Gastroenterol       Date:  2018-08-15       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.